Empatica has received the US FDA 510(k) clearance for its Health Monitoring Platform for Parkinson’s, enabling the company to extend...
Novo Nordisk has begun a late-stage clinical trial to evaluate whether lower doses of its Wegovy pill can still deliver...
SandboxAQ has introduced AQPotency, a LQM designed to virtually screen and predict the potential of drug candidates without the need...
Aqua Medical has treated the first West Coast patient in the RESTORE-I trial, a FDA-approved IDE study assessing its PIMA...
Lynch Regenerative Medicine has completed participant enrolment in a Phase II trial assessing the rhPDGF-BB as an adjunctive therapy for...
BeOne Medicines, the BeOne Care Foundation, and The Max Foundation have extended their Brukinsa access programme for CLL until 2028.The...
Johnson & Johnson (J&J) has received the US Food and Drug Administration (FDA) 510(k) clearance for the MONARCH QUEST 3...
Leal Therapeutics has completed a $30m extension of its Series A financing to support advancement of its investigational therapies for...
Fulcrum Therapeutics and Slate Medicines have signed a definitive agreement to merge in an all-stock transaction backed by a $245m...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.